Intec Pharma (Israel) Financial Indicators Patterns

NTEC -- Israel Stock  

null 1,495  5.00  0.34%

We strongly advise you to harness Intec Pharma fundamental analysis to see if markets are presently mispricing the organization. In other words this interface allows you to validate available fundamentals of Intec Pharma as well as the relationship between them. . We found seventeen available reported financial drivers for Intec Pharma which can be compared to its competitors. Use Intec Pharma Ltd Current Ratio, Cash Flow from Operations, Number of Employees, as well as the relationship between Book Value Per Share and Earnings Per Share to make sure your decision on pricing Intec Pharma is adequate. Use Intec Pharma to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Intec Pharma to be traded at 1569.75 in 30 days

Intec Pharma Company Summary

Intec Pharma competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, and Israel Chemicals. Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel. Intec Pharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 70 people.

Intec Pharma Number of Employees vs Beta

Intec Pharma Ltd is rated below average in number of employees category among related companies. It is considered to be number one stock in beta category among related companies totaling about  0.01  of Beta per Number of Employees. The ratio of Number of Employees to Beta for Intec Pharma Ltd is roughly  67.96 

Intec Pharma Market Fundamentals

 Quote1495.00
 Change(%) 0.34%
 Change5.00 
 Open1490.0
 Low1490.0
 High1500.0
 Volume1.000
 ExchangeTLV

Distress Rating

Intec Pharma Financial Distress Probability

41% 
Chance of Financial Distress
Intec Pharma Ltd has less than 41 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Intec Pharma

Compare Intec Pharma To Peers

Intec Pharma Opportunity Range

October 19, 2018 Opportunity Range

Please see also Stocks Correlation. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com